Dec 22 2018
This article summaries recent progresses published in high impact journals on lung cancer research and treatment. Kindly provided by Ms. Dandan Hu (胡丹丹), a MSI from Roche China, will continually update for every month. Article in Chinese. LANCET SERIES Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study Lancet Oncol; Published […]
Dec 17 2018
The 2018 Annual Scientific Symposium of MSCO was successfuly held on September 29, 2018 at Mandarin Oriental Hotel, Macau. Invited speaker including Dr. Tongyu Li from Sun Yat-sen University Cancer Center, Dr, Ding Yu and Dr. Huijing Wu from Hubei Cancer Center, Dr. Yizhun Zhu, Prof. Elaine,Leung from MUST, Dr. Xingxiang Pu from Hunan Cancer […]
Dec 17 2018
This article summaries recent progresses published in high impact journals on lung cancer research and treatment. Kindly provided by Ms. Dandan Hu (胡丹丹), a MSI from Roche China, will continually update for every month. Article in Chinese. LANCET SERIES Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study Lancet Oncol 2018；Published Online […]
Dec 17 2018
This article summaries recent progresses published in high impact journals on lung cancer research and treatment. Kindly provided by Ms. Dandan Hu (胡丹丹), a MSI from Roche China, will continually update for every month. Article in Chinese. THE NEW ENGLAND JOURNAL OF MEDICINE First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer published on September […]
Dec 17 2018
This article summaries recent progresses published in high impact journals on lung cancer research and treatment. Kindly provided by Ms. Dandan Hu (胡丹丹), a MSI from Roche China, will continually update for every month. Article in Chinese. LANCET SERIES Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis Lancet […]
Sep 17 2018
Dr.Qi Biao Wu reported that Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-smallcell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines. Globally, lung cancer remains the most common cancer and the leading cause of cancer death. In the United States, death from lung cancer accounts for approximately 25% of all cancer […]
Aug 30 2018
Dr Elaine Lai Han Leunget al reported thatGossypol inhibits non-small cell lung cancer cells proliferation by targeting EGFRL858R/T790M Overexpression of epidermal growth factor receptor (EGFR) has been reported to be implicated in the pathogenesis of non-small cell lung cancer (NSCLC). Several EGFR inhibitors have been used in clinical treatment of NSCLC, but the emergence […]
Dec 22 2018
2018 Member Meetings
2018 Member meeting of MSCO was held on Sep 29, 2018. During this meeting many important issues were voted for approve, regarding financial and regulations on management.
Read More
By Yabing • MSCO Activities • 0